Skip to main content
Download PDF

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Journal of Hematology & Oncology volume 15, Article number: 175 (2022) Cite this article

The Original Article was published on 10 April 2018

Correction: Journal of Hematology & Oncology (2018) 11:53 https://doi.org/10.1186/s13045-018-0597-1

The original article contained errors in Fig. 7. A549 vector in panel a should be labelled as vehicle and was duplicated with A549 vector in panel c. SKLU DACH1 in panel e should be labelled SKLU DACH1-vehicle, and was duplicated with SKLU CXCL-Ab in panel a. We repeated this experiment and presented right images with corresponding analysis.

Fig. 7
figure 7

Overexpression of DACH1 controlled the CXCL8-induced migration of lung cancer cell in vitro. a Anti-CXCL8 antibody controlled the migration of SKLU and A549 cell lines, b the corresponding quantitative graph showed statistical significance. c The migration of ADC cells was inhibited in the presence of excessive DACH1 expression, d the corresponding quantitative graph showed statistical significance. e Human CXCL8 cytokine restored the DACH1-induced migration inhibition of SKLU-DACH1 and A549-DACH1 cells, f the corresponding quantitative graph showed statistical significance

Full size image

Author information

Author notes

  1. Qian Liu and Anping Li: Equal contributors

Authors and Affiliations

  1. Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China

    Qian Liu, Shengnan Yu, Shuang Qin, Na Han & Kongming Wu

  2. Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People’s Republic of China

    Anping Li & Xinwei Han

  3. Pennsylvania Cancer and Regenerative Medicine Research Center, Wynnewood, PA, 19096, USA

    Richard G. Pestell

Authors
  1. Qian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shengnan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuang Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Na Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Richard G. Pestell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xinwei Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kongming Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xinwei Han or Kongming Wu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Q., Li, A., Yu, S. et al. Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis. J Hematol Oncol 15, 175 (2022). https://doi.org/10.1186/s13045-022-01393-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-022-01393-2

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us